Active Pharmaceutical Ingredient

Adalimumab API Manufacturer & Supplier in India

Also known as: Humira

CAS: 331731-18-3 Immunology / TNF-Alpha Inhibitor (Biologic) Pharma Grade / Injectable Biologic GMP Certified Aurangabad, Maharashtra, India
Adalimumab API — Mediocon Inc
Adalimumab — Pharmaceutical Grade API

Product Overview

CAS No: 331731-18-3  |  Recombinant Human IgG1 Monoclonal Antibody (Biologic)  |  ~148 kDa

Adalimumab is a pharmaceutical-grade Active Pharmaceutical Ingredient in the Immunology / TNF-Alpha Inhibitor (Biologic) category. Mediocon Inc supplies high-purity Adalimumab API (CAS 331731-18-3) from our GMP-certified facility in Aurangabad, Maharashtra, India. We cater to pharmaceutical manufacturers, formulators, and research organizations worldwide.

Adalimumab is primarily associated with: Fully human anti-TNF-alpha monoclonal antibody. Mediocon's Adalimumab meets the highest pharmacopoeial standards and is manufactured under WHO-GMP compliant conditions for consistent quality and purity.

Key Features

  • High-purity pharmaceutical grade API (NLT 95.0% assay)
  • Pharma Grade / Injectable Biologic compliant with full analytical verification
  • Full CoA, MSDS/SDS, and COO documentation with every batch
  • GMP certified manufacturing under ISO 9001:2015 QMS

Applications & Therapeutic Uses

  • Rheumatoid arthritis and psoriatic arthritis treatment
  • Ankylosing spondylitis management
  • Crohn's disease and ulcerative colitis treatment
  • Plaque psoriasis and biosimilar monoclonal antibody development

Why Choose Mediocon

  • ISO 9001:2015 & WHO-GMP certified manufacturing
  • Consistent batch-to-batch quality with full CoA
  • Export-ready documentation: COO, MSDS, DMF support
  • Flexible MOQ for both R&D and commercial scale
  • Dedicated QA support for regulatory filings (FDA, EMA, WHO)

Product Specifications

Product NameAdalimumab
Also Known AsHumira
CAS Number331731-18-3
Molecular FormulaRecombinant Human IgG1 Monoclonal Antibody (Biologic)
Molecular Weight~148 kDa
CategoryImmunology / TNF-Alpha Inhibitor (Biologic)
AppearanceClear to slightly opalescent, colourless to pale yellow solution for injection
GradePharma Grade / Injectable Biologic
StorageStore at 2-8°C (do not freeze); protect from light

Analytical Specifications

ParameterSpecification
Purity (SEC-HPLC)NLT 95.0%
EndotoxinNMT 5 EU/mg (LAL test)
AggregatesWithin validated limits
IdentitySDS-PAGE / Peptide Mapping Compliant
SterilityComplies with pharmacopoeia
BioburdenComplies with pharmacopoeia
PackingCold-chain packaging / single-use vials, as per requirement

Sourcing, Regulatory & Export Information

Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Adalimumab (CAS 331731-18-3) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.

Our Adalimumab is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (Pharma Grade / Injectable Biologic). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.

Export Markets

  • USA — FDA-registered facility; DMF support available for ANDA/NDA filings
  • Europe — EMA-compliant documentation; CEP/EDMF support on request
  • Africa & Middle East — WHO-GMP certified; competitive pricing for emerging markets
  • Southeast Asia — established logistics network; temperature-controlled shipments
  • India domestic — schedule H/X compliance; all state licensing documentation provided

Quality & Compliance

  • ISO 9001:2015 certified quality management system
  • GMP-certified manufacturing facility, Aurangabad, Maharashtra
  • Full batch traceability from raw material to finished API
  • Stability data available (ICH Q1A guidelines) for regulatory submissions
  • Dedicated QA team for customer audits and regulatory queries

Frequently Asked Questions — Adalimumab API

What is the minimum order quantity for Adalimumab API?
Mediocon Inc supplies Adalimumab with a minimum order quantity of 100 mg (cold-chain sample available). We accommodate both small R&D quantities and large commercial-scale orders. Contact our sales team at akshay@mediocon.com or +91 9309999757 for a tailored quote.
What pharmacopoeial grades of Adalimumab does Mediocon supply?
We supply Adalimumab conforming to Pharma Grade / Injectable Biologic pharmacopoeial standards. Each batch is tested against full specifications and released with a Certificate of Analysis. Custom specifications can be accommodated for regulated markets.
What documentation is provided with Adalimumab API?
Every shipment of Adalimumab comes with: Certificate of Analysis (CoA), MSDS/SDS, Certificate of Origin (COO), and Drug Master File (DMF) support on request. We also provide GMP certification, ISO 9001:2015 compliance documentation, and full regulatory support for filings in USA (FDA), Europe (EMA), and other markets.
What is the lead time and shipping for Adalimumab bulk orders?
Standard lead time for Adalimumab is 2-4 weeks for standard orders; expedited shipments possible for urgent requirements. We ship to 40+ countries worldwide using approved pharmaceutical-grade packaging.
💬
Mediocon AI
Hello 👋 How can I help you today?